Novel antithrombotic effects of dabigatran in patients with non-valvular atrial fibrillation

Keisuke Tsuda; Tatsunori Natori; Mie Shimizu; Yoko Ishigaku; Kiyotaka Oi; Shinsuke Narumi; Asami Kamada; Makiko Yoshida; Kazumasa Oura; Tetsuya Maeda; Yasuo Terayama

doi:10.1016/j.thromres.2020.02.017

Novel antithrombotic effects of dabigatran in patients with non-valvular atrial fibrillation

Thromb Res. 2020 May:189:1-4. doi: 10.1016/j.thromres.2020.02.017. Epub 2020 Feb 21.

Authors

Affiliations

¹ Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan.
² Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate 020-8505, Japan. Electronic address: mie8718@gmail.com.

PMID: 32120029
DOI: 10.1016/j.thromres.2020.02.017

No abstract available

Keywords: Automated platelet aggregometry; Dabigatran; Non-valvular atrial fibrillation (NVAF); Thrombin inhibitor; Thrombin-induced platelet aggregation.

Publication types

Letter

MeSH terms

Anticoagulants / pharmacology
Anticoagulants / therapeutic use
Antithrombins / pharmacology
Antithrombins / therapeutic use
Atrial Fibrillation* / drug therapy
Dabigatran / pharmacology
Dabigatran / therapeutic use
Fibrinolytic Agents / pharmacology
Humans
Platelet Aggregation
Stroke* / drug therapy
Stroke* / prevention & control

Substances

Anticoagulants
Antithrombins
Fibrinolytic Agents
Dabigatran